By Sherri Oslick --
About Court Report: Each week we will report briefly on recently filed biotech and pharma cases.
Main Hastings LLC v. Pfizer, Inc.
2:10-cv-00599; filed December 29, 2010 in the Eastern District of Texas
False marking based on Pfizer's marking of thirteen different products from its Animal Health Division with various patents (twenty in total) that have expired. View the complaint here.
IDEXX Laboratories Inc. v. Abbott Laboratories Inc.
1:10-cv-01140; filed December 28, 2010 in the District Court of Delaware
Infringement of U.S. Patent No. 5,627,026 ("Detection of Both an Antibody and an Antigen in a Single Sample Aliquot," issued May 6, 1997) based on Abbott's manufacture and sale of its Architect HIV Ag/Ab Combo assay. View the complaint here.
Life Technologies Corp. v. Biosearch Technologies Inc.
3:10-cv-02665; filed December 27, 2010 in the Southern District of California
Infringement of U.S. Patent No. 7,160,997 ("Methods of Using FET Labeled Oligonucleotides That Include a 3' à 5' Exonuclease Resistant Quencher Domain and Compositions for Practicing the Same," issued on January 9, 2007) based on Biosearch's manufacture and sale of its BHQplus fluorescent-labeled probes for DNA analysis. View the complaint here.
Pfizer Inc. et al. v. Dr. Reddy's Laboratories Ltd. et al.
1:10-cv-01135; filed December 27, 2010 in the District Court of Delaware
• Plaintiffs: Pfizer Inc.; Pfizer Ireland Pharmaceuticals; Warner-Lambert Co.; Warner-Lambert Company LLC
• Defendants: Dr. Reddy's Laboratories Ltd.; Dr. Reddy's Laboratories Inc.
Infringement of U.S. Patent No. 5,969,156 ("Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)," issued October 19, 1999) based on Dr. Reddy's filing of an ANDA to manufacture a generic version of Pfizer's Lipitor® (atorvastatin calcium, used to treat high cholesterol and heart disease). View the complaint here.
Comments